指南与共识复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

SCAI心源性休克分类临床专家共识声明:2019年4月获美国心脏病学会、美国心脏协会、美国重症医学会和美国胸外科医师学会认可

SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019.
指南 / 共识 · Catheter Cardiovasc Interv · 2019-05-19
一句话结论SCAI提出A至E五阶段心源性休克分类,B与C的区别在于是否存在低灌注,D为初始干预至少观察30分钟未恢复稳定,E为极度不稳定常伴心血管崩溃。

该共识由心血管造影与干预学会召集多学科专家制定心源性休克分类方案。分类从A到E共五期:A为风险期,B为休克开始期,C为典型心源性休克,D为恶化期,E为极度期。B与C的区别在于C期及以上存在低灌注;D期指初始干预至少观察30分钟仍未恢复稳定和充分灌注;E期为极度不稳定、常伴心血管崩溃。该分类简单、可跨院前至ICU全救治链应用,但尚需未来验证研究评估其效用和预后意义。

要点

  • SCAI心源性休克分为A至E五期:A为风险期,B为休克开始期,C为典型心源性休克,D为恶化期,E为极度期。
  • B期与C期的区别在于是否存在低灌注,C期及以上存在低灌注。
  • D期指初始干预至少观察30分钟后仍未恢复稳定和充分灌注。
  • E期为极度不稳定、常伴心血管崩溃的患者。
  • 该分类简单、可从院前到ICU全救治链应用,但尚需未来验证研究评估其效用和预后意义。

适用人群与场景

  • 适用于从院前急救人员到重症监护人员的全救治链中心源性休克患者。

诊断标准与关键阈值

  • SCAI心源性休克分类:A期为风险期,B期为休克开始期,C期为典型心源性休克,D期为恶化期,E期为极度期。
  • B期与C期的区别在于是否存在低灌注,C期及以上存在低灌注。
  • D期指初始干预至少观察30分钟后仍未恢复稳定和充分灌注。
  • E期为极度不稳定、常伴心血管崩溃。

红旗征与不能漏的情况

  • E期为极度不稳定、常伴心血管崩溃。
  • D期指初始干预至少观察30分钟后仍未恢复稳定和充分灌注。

研究设计与关键结果

  • 由心血管造影与干预学会召集的多学科专家组制定心源性休克分类方案,来自介入心脏病学、晚期心力衰竭、非侵入性心脏病学、急诊医学、重症医学和心脏护理的代表共同协作开发。
  • 提出了从A到E描述心源性休克阶段的系统:A为风险期,B为休克开始期,C为典型心源性休克,D为恶化期,E为极度期。
  • B与C的区别在于低灌注的存在,C期及以上存在低灌注;D期指初始干预至少观察30分钟后仍未恢复稳定和充分灌注;E期为极度不稳定、常伴心血管崩溃。

证据类型、等级与局限

  • 证据类型:临床专家共识声明。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该分类系统简单,可从院前急救人员到重症监护人员全救治链临床应用,但作者指出尚需未来验证研究评估其效用和预后意义。

指南或共识出处

  • SCAI心源性休克分类临床专家共识声明,由心血管造影与干预学会发布,2019年4月获美国心脏病学会、美国心脏协会、美国重症医学会和美国胸外科医师学会认可。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The outcome of cardiogenic shock complicating myocardial infarction has not appreciably changed in the last 30 years despite the development of various percutaneous mechanical circulatory support options. It is clear that there are varying degrees of cardiogenic shock but there is no robust classification scheme to categorize this disease state.

METHODS: A multidisciplinary group of experts convened by the Society for Cardiovascular Angiography and Interventions was assembled to derive a proposed classification schema for cardiogenic shock. Representatives from cardiology (interventional, advanced heart failure, noninvasive), emergency medicine, critical care, and cardiac nursing all collaborated to develop the proposed schema.

RESULTS: A system describing stages of cardiogenic shock from A to E was developed. Stage A is "at risk" for cardiogenic shock, stage B is "beginning" shock, stage C is "classic" cardiogenic shock, stage D is "deteriorating", and E is "extremis". The difference between stages B and C is the presence of hypoperfusion which is present in stages C and higher. Stage D implies that the initial set of interventions chosen have not restored stability and adequate perfusion despite at least 30 minutes of observation and stage E is the patient in extremis, highly unstable, often with cardiovascular collapse.

CONCLUSION: This proposed classification system is simple, clinically applicable across the care spectrum from pre-hospital providers to intensive care staff but will require future validation studies to assess its utility and potential prognostic implications.

来源:Catheter Cardiovasc Interv,查看原文。版权归原作者所有。

参考来源

  1. Baran DA, Grines CL, Bailey S, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019. PMID: 31104355. doi:10.1002/ccd.28329

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。